p70S6K/Akt dual inhibitor DIACC3010 is efficacious in preclinical models of gastric cancer alone and in combination with trastuzumab.

Sci Rep · 2023 · PMC10520030 · PMID 37749105

Europe PMC DOI

hedged sentence

0.0900

closest p · 1.8× alpha

0.0900

boldest claim

The sentences

approached significancep = 0.09so close (0.05 < p ≤ 0.1)

Comparing data from Group A (DIACC3010 sensitive) versus all other groups approached significance at p = 0.09.

also in 8,237 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.